Suppr超能文献

H1和H2组胺受体激动剂及拮抗剂对大鼠睡眠和觉醒的影响。

Effects of H1- and H2-histamine receptor agonists and antagonists on sleep and wakefulness in the rat.

作者信息

Monti J M, Pellejero T, Jantos H

出版信息

J Neural Transm. 1986;66(1):1-11. doi: 10.1007/BF01262953.

Abstract

The H1-receptor agonist 2-thiazolylethylamine (2-TEA) given by i.c.v. route dose-dependently increased wakefulness (W) and decreased NREM sleep (NREMS) and REM sleep (REMS) in rats prepared for chronic sleep recordings. The H1-receptor antagonists pyrilamine and diphenhydramine given by i.p. route decreased W and increased NREMS. Pyrilamine prevented the increase of W and decrease of NREMS produced by 2-TEA. However, REMS reduction was not antagonized, what tends to suggest that two different mechanisms could be involved in the 2-TEA-induced effects on NREMS and REMS. Cimetidine which blocks H2-receptors, when given by i.p. route showed no significant effects on sleep and W. Administration of the H2-receptor agonist dimaprit and the H2-receptor antagonists cimetidine, metiamide and ranitidine by i.c.v. route induced the appearance of high voltage spikes at cortical leads, thus leaving inconclusive the matter of their effects on sleep and wakefulness. Our results tend to support the proposal that the H1-receptor intervenes in sleep-wakefulness regulation. Limitations in the available H2-receptor agonists and antagonists presently preclude a more detailed analysis of the role of H2-receptors on sleep and W.

摘要

在为慢性睡眠记录准备的大鼠中,通过脑室内(i.c.v.)途径给予H1受体激动剂2-噻唑基乙胺(2-TEA),可剂量依赖性地增加觉醒(W),并减少非快速眼动睡眠(NREMS)和快速眼动睡眠(REMS)。通过腹腔内(i.p.)途径给予H1受体拮抗剂吡苄明和苯海拉明可减少W并增加NREMS。吡苄明可阻止2-TEA引起的W增加和NREMS减少。然而,REMS的减少未被拮抗,这倾向于表明2-TEA对NREMS和REMS的诱导作用可能涉及两种不同的机制。通过腹腔内途径给予的阻断H2受体的西咪替丁对睡眠和W无显著影响。通过脑室内途径给予H2受体激动剂二甲双胍以及H2受体拮抗剂西咪替丁、甲硫米特和雷尼替丁,会在皮层导联诱发出高电压尖峰,因此它们对睡眠和觉醒的影响尚无定论。我们的结果倾向于支持H1受体参与睡眠-觉醒调节的提议。目前可用的H2受体激动剂和拮抗剂的局限性使得无法对H2受体在睡眠和W中的作用进行更详细的分析。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验